Amylyx Pharmaceuticals In...

NASDAQ: AMLX · Real-Time Price · USD
8.01
-0.40 (-4.76%)
At close: Aug 15, 2025, 3:59 PM
8.08
0.87%
After-hours: Aug 15, 2025, 06:49 PM EDT

Amylyx Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.85 20.09 -12.39 -11.9
PEG Ratio
0.00 -0.16 -0.13 -0.13
PS Ratio
2.95 2.60 110.55 3.67K
PB Ratio
1.56 2.28 7.22 -6.92
P/FCF Ratio
-1.53 92.69 -13.47 -13.91
P/OCF Ratio
-1.54 83.03 -13.66 -13.98
OCF/S Ratio
-1.92 0.03 -8.09 -262.45
Debt / Equity Ratio
0.01 0.01 0.02 n/a
Quick Ratio
6.67 5.20 7.99 5.84
Current Ratio
6.67 5.66 8.20 5.84
Asset Turnover
0.45 0.74 0.06 0.00
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-1.83 0.11 -0.58 0.58
Return on Assets
-1.56 0.10 -0.51 -0.83
Return on Invested Capital
-1.89 0.08 -0.58 -0.94
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-0.43 0.93 0.87 0.82
Net Profit Margin
-3.45 0.13 -8.92 -308.35
Pretax Profit Margin
-3.46 0.14 -8.89 -308.53
Operating Profit Margin
-3.6 0.10 -9.06 -290.13
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-3.33 0.10 -9.04 -289.95